![]() |
Volumn 31, Issue 4, 1999, Pages 1790-1792
|
Therapeutic strategies for optimal use of novel immunosuppressants
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
RAPAMYCIN;
TACROLIMUS;
CONFERENCE PAPER;
DISEASE SEVERITY;
DRUG MONITORING;
GRAFT REJECTION;
GRAFT SURVIVAL;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
ORGAN TRANSPLANTATION;
PRIORITY JOURNAL;
SURVIVAL;
ACUTE DISEASE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MONITORING, PHYSIOLOGIC;
ORGAN TRANSPLANTATION;
|
EID: 0032995736
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(99)00170-0 Document Type: Conference Paper |
Times cited : (13)
|
References (26)
|